PharmaGraphX

Log in Get Started

Dupilumab

Dupixent

Uncategorized

Standard

Half-life

~3 weeks

Protein Binding

N/A

Metabolized By

N/A

External

Drugs.com

Mechanism of action

Human monoclonal antibody blocking IL-4Ra, inhibiting IL-4 and IL-13 signaling

Recorded indications

From the drug index — may include conditions studied rather than approved indications

·Atopic Dermatitis
·Healthy Volunteers
·Chronic Obstructive Pulmonary Disease
·Chronic Rhinosinusitis (Diagnosis)
·Pruritus

Interactions

No curated interaction pairs are recorded for Dupilumab. This is not a statement that none exist — check a full interaction reference before combining.

Common adverse effects

Injection site reactions
Conjunctivitis
Nasopharyngitis
Headache

Pharmacokinetics

Half-life: ~3 weeks
Protein binding: N/A

Pregnancy & lactation

Not recorded for Dupilumab. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.

Sources

Assembled from: drug index, curated drug database.

Not a substitute for clinical judgement